Lisata Therapeutics Stock Market Value
| LSTA Stock | USD 3.73 0.02 0.54% |
| Symbol | Lisata |
Lisata Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. If investors know Lisata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lisata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lisata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lisata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lisata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lisata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lisata Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lisata Therapeutics.
| 01/13/2024 |
| 01/07/2025 |
If you would invest 0.00 in Lisata Therapeutics on January 13, 2024 and sell it all today you would earn a total of 0.00 from holding Lisata Therapeutics or generate 0.0% return on investment in Lisata Therapeutics over 360 days. Lisata Therapeutics is related to or competes with Lixte Biotechnology, Imunon, Rezolute, XOMA, Protagenic Therapeutics, Tempest Therapeutics, and Pulmatrix. Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellula... More
Lisata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lisata Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lisata Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.14 | |||
| Information Ratio | 0.0998 | |||
| Maximum Drawdown | 19.57 | |||
| Value At Risk | (4.56) | |||
| Potential Upside | 7.84 |
Lisata Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lisata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lisata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Lisata Therapeutics historical prices to predict the future Lisata Therapeutics' volatility.| Risk Adjusted Performance | 0.0942 | |||
| Jensen Alpha | 0.4427 | |||
| Total Risk Alpha | 0.3484 | |||
| Sortino Ratio | 0.1357 | |||
| Treynor Ratio | 8.14 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lisata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lisata Therapeutics Backtested Returns
Lisata Therapeutics appears to be moderately volatile, given 3 months investment horizon. Lisata Therapeutics has Sharpe Ratio of 0.0914, which conveys that the firm had a 0.0914% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Lisata Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Lisata Therapeutics' Downside Deviation of 3.14, risk adjusted performance of 0.0942, and Mean Deviation of 2.64 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lisata Therapeutics holds a performance score of 7. The company secures a Beta (Market Risk) of 0.0545, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lisata Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Lisata Therapeutics is expected to be smaller as well. Please check Lisata Therapeutics' expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether Lisata Therapeutics' current price movements will revert.
Auto-correlation | -0.32 |
Poor reverse predictability
Lisata Therapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Lisata Therapeutics time series from 13th of January 2024 to 11th of July 2024 and 11th of July 2024 to 7th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lisata Therapeutics price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Lisata Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Lisata Therapeutics lagged returns against current returns
Autocorrelation, which is Lisata Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lisata Therapeutics' stock expected returns. We can calculate the autocorrelation of Lisata Therapeutics returns to help us make a trade decision. For example, suppose you find that Lisata Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lisata Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lisata Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lisata Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lisata Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Lisata Therapeutics Lagged Returns
When evaluating Lisata Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lisata Therapeutics stock have on its future price. Lisata Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lisata Therapeutics autocorrelation shows the relationship between Lisata Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Lisata Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Lisata Therapeutics Correlation, Lisata Therapeutics Volatility and Lisata Therapeutics Alpha and Beta module to complement your research on Lisata Therapeutics. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Lisata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.